Pharmaceutical Company Mylan
Outcome
OIG enforcement action against Pharmaceutical Company Mylan for healthcare fraud. Penalty: $20.3 million.
Details
Pharmaceutical Company Mylan — OIG Enforcement (2026)
OIG took enforcement action against Pharmaceutical Company Mylan in MA in 2026 involving healthcare fraud violations in the Independent Pharmacies sector.
Penalty: $20.3 million
Violation types: Healthcare Fraud
Entity type: Pharmacy
Penalty type: Settlement
Location: MA
Source: Pharmaceutical Company Mylan to Pay $20.3 Million for Underpaying Rebates on Epipens for Masshealth Members
How Crucible Prevents This
Crucible's compliance monitoring controls for Independent Pharmacies would have detected the patterns underlying this violation through automated screening, documentation enforcement, and real-time alert escalation.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works